Chief Science Officer
Aridhia Digital Research Environment
Dr. Jeff Barrett is Senior Vice-President at the Critical Path Institute heading the Rare Disease Cures Accelerator, Data Analytics Platform and a critical liaison between C-Path and the pharmaceutical industry, foundations, and other key stakeholders, growing C-Path’s portfolio in drug development solutions, with a focus, but not limited to model-informed drug development (MIDD) and real-world data (RWD) technologies. Jeff was previously Head of Quantitative Sciences at the Bill & Melinda Gates Medical Research Institute. Prior to MRI, he was Vice President, of Translational Informatics at Sanofi Pharmaceuticals. Jeff spent 10+ years at the University of Pennsylvania where he was Professor, Pediatrics and Director, Laboratory for Applied PK/PD at the Children’s Hospital of Philadelphia. Jeff received his B.S. in Chemical Engineering from Drexel University and Ph.D. in Pharmacokinetics from University of Michigan. He has co-authored over 185 manuscripts, is fellow of ACCP, AAPS, ISOP and the recipient of numerous honors including ACCP awards for Young Investigator (2002) and Mentorship in Clinical Pharmacology (2007) and the AAPS Award in Clinical Pharmacology and Translational Research (2011). Dr. Barrett was awarded for Exceptional Innovation and Advancing the Discipline of Pharmacometrics at the International Society for Pharmacometrics (2013). He is co-Specialty Chief Editor of Frontiers in Obstetric and Pediatric Pharmacology Journal and an active member of the Child Health and Human Development Pediatrics Subcommittee as a study section reviewer. He was a past acting chair of the FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; a voting member of the committee for 8 years.
Symposium 3: Novel Approaches for the Prediction of Drug Effects in Children
Sunday, September 10, 2023
1:30 PM - 5:00 PM PT
Disclosure(s): No financial relationships to disclose
Sunday, September 10, 2023
1:30 PM - 5:00 PM PT
Disclosure(s): No financial relationships to disclose